Acne Medications Market Size, Share & COVID-19 Impact Analysis, By Product (Retinoids, Antibiotics, Isotretinoin, and Others), By Route of Administration (Oral and Topical), By Age Group (10 to 17, 18 to 44, 45 to 64, and 65 Above), By Distribution Channel (Hospital Pharmacies and Retail & Online Pharmacies), and Regional Forecast, 2023-2029
The global Acne Medications Market size was valued at USD 8.99 billion in 2021. The market is projected to grow from USD 9.36 billion in 2022 to USD 12.97 billion by 2029, exhibiting a CAGR of 4.8% during the forecast period.
This vital information is presented by Fortune Business Insights™, in its report titled, “Acne Medications Market, 2022-2029.” Factors such as the rising prevalence of skin disorders and rising clinical approval for drugs will boost the growth of the market during the forecast period. Additionally, launching novel drugs will increase the footprint of the market.
Request Sample PDF https://www.fortunebusinessinsights.com/enquiry/sample/acne-treatment-market-103361
The increasing prevalence of acne worldwide and new product launches will drive market growth.
In addition, the introduction of a wide range of therapeutic products, including retinoid, isotrettinoids, and antibiotics in oral and topical forms, has contributed to the growth of the market. Increase your presence in the market. Also, an increasing number of new drug launches and clinical trials by prominent players will boost the market growth.
Increasing side effects associated with the current market product range will limit the market growth during the forecast period.
Inorganic Growth Characteristics and Product Developments to Help Prominent Players Establish Advantage
The Acne Medications sector is characterized by the presence of many large and small players operating across the globe. Leading players are establishing their market position through diversified market portfolios that trigger higher revenue growth. For example, Sun Pharmaceutical Industries Ltd. has announced that it will launch WINLEVI (clascoterone) cream 1% in the US in November 2021 for the topical treatment of acne vulgaris in his patients aged 12 and older. Did. The dominant players in the market are Allergan, Galderma S.A. and Bosch Health Companies. The competitive landscape of the market focuses on players with small domestic products in their portfolios.
Company Overview:
Company overview provides the information about location of the company where it is headquartered along with the established year, employee strength as of 2021, regions where the company is operating and the key business areas.
Fiscal Overview:
Overall revenue for the year 2021 and 2022 is provided in the sub title “Financial Performance” (public listed companies) along with the analysis and explanation of the increase or decrease in the same due to factors such as mergers and acquisition, profit or loss in any strategic business unit (SBUs) and others.
Product Benchmarking:
Product benchmarking comprises the comprehensive list of products pertaining to the respective market along with the application and key features.
Get a Quote, Click Here: https://www.fortunebusinessinsights.com/enquiry/get-a-quote/acne-treatment-market-103361
Strategic Initiatives:
Insights pertaining to the new product launch, strategic collaboration, mergers and acquisition, regulatory approval, and other developments by the company in market are covered under strategic initiatives section.
The report also covers in-depth explanations, competitive scenarios, and a broad product portfolio with a broad product portfolio of key players in Global Dental Market and SWOT analysis adopted by competitors. This report provides Porter analysis, PESTEL analysis and market appeal to help you better understand macro and microscopic market scenarios.
Top Players:
- Allergan (Ireland)
- Botanix Pharmaceuticals (Australia)
- GALDERMA (Switzerland)
- Bausch Health Companies Inc. (U.S.)
- GlaxoSmithKline Plc. (U.K.)
- Bayer AG (Germany)
- Valeant Pharmaceutical International, Inc. (U.S.)
- Johnson and Johnson Services, Inc. (U.S.)
- Pfizer Inc. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Israel)
Regional Insights:
North America will dominate during the forecast period due to growing consumer concerns of the Acne Medications market share.
In addition, new product launches by prominent players in the region and a significant increase in patient numbers will boost the market presence.
Europe will gain significant market share in terms of global contribution due to the growing patient pool in the region coupled with increased investment in RandD for the treatment of dermatological diseases. Increasing adoption of advanced treatments and solutions will continue to push the market share to higher volumes.
Asia-Pacific will host the fastest-growing CAGR due to rising population awareness of multiple drugs coupled with an increasing number of companies entering the region.
Table of Content from Acne Treatment Market:
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Prevalence of Acne, By Region/ Country, 2021
- New Product Launches, By Key Players
- Pipeline Analysis, for Key Players
- Key Industry Developments – Mergers, Acquisitions, etc.
- Global Acne Medications Market Analysis, Insights and Forecast, 2018-2029
- Key Findings / Summary
- Market Analysis, Insights and Forecast By Product
- Retinoids
- Antibiotics
- Isotretinoin
- Others
- Market Analysis, Insights and Forecast By Route of Administration
- Market Analysis, Insights and Forecast By Age Group
- 10 to 17
- 18 to 44
- 45 to 64
- 65 and Above
- Market Analysis, Insights and Forecast By Distribution Channel
- Hospital Pharmacies
- Retail and Online Pharmacies
- Market Analysis, Insights and Forecast By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
TOC Continued…
Quick Buy This Research Report for More Details https://www.fortunebusinessinsights.com/checkout-page/103361
About us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
Pune – 411045, Maharashtra, India.
Phone:
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email:[email protected]
Press Release Distributed by The Express Wire
To view the original version on The Express Wire visit At 4.8% CAGR, Acne Medications Market Size Worth USD 12.97 billion by 2029
